31442913|t|Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia.
31442913|a|Hypoxia and acidity provide microenvironment for selection under evolutionary pressure and proliferation in cancer cells. Carbonic anhydrases (CAs) are a superfamily of metalloenzymes present in all life kingdoms, equilibrating the reactions among CO2, bicarbonate and H+. CA9, a membrane-associated alpha-CA, has been a drug target for various cancers. Whereas iron is essential not only for cancer cells but also for all the lives on earth, little is known on the association among hypoxia, iron metabolism, extracellular acidity and redox regulation. Malignant mesothelioma (MM), an aggressive tumor with poor prognosis, is an intriguing model in that asbestos-associated pathogenesis includes excess iron environment during carcinogenesis. Re-analysis of rat asbestos-induced MM model revealed an inverse association between high CA9 expression and survival. Here we used human MMs to identify the molecular events surrounding CA9 from the viewpoint of iron metabolism. CA9 expression was significantly higher in MM cells than in MeT-5A mesothelial cells, which was further amplified under hypoxia (1%O2) with increased catalytic Fe(II). CA9 suppression by inhibitors (S4 and U104) decreased viability and migration of MM cells, accompanied by overexpression of TFRC, IREB1/2 and FPN1(SLC40A1) and by downregulation of FTH/FTL. This expressional pattern was similar to that of erastin-induced ferroptosis in the same cells. Furthermore, we observed mitochondrial fission and enhanced autophagy with increased catalytic Fe(II) in both mitochondria and lysosomes after CA9 inhibition, accompanied by increased peroxides, mitochondrial O2- and lipid peroxidation. The eventual cell death was significantly inhibited by deferoxamine, ferrostatin-1 and Z-VAD-FMK, suggesting a mixed cell death of ferroptosis and apoptosis. Therefore, CA9 plays a role in equilibrating among hypoxia, iron metabolism and redox regulation in MM cells.
31442913	0	20	Carbonic anhydrase 9	Gene	768
31442913	43	54	ferroptosis	Disease	
31442913	68	90	malignant mesothelioma	Disease	MESH:D000086002
31442913	97	104	hypoxia	Disease	MESH:D000860
31442913	106	113	Hypoxia	Disease	MESH:D000860
31442913	214	220	cancer	Disease	MESH:D009369
31442913	354	357	CO2	Chemical	MESH:D002245
31442913	359	370	bicarbonate	Chemical	MESH:D001639
31442913	379	382	CA9	Gene	768
31442913	451	458	cancers	Disease	MESH:D009369
31442913	468	472	iron	Chemical	MESH:D007501
31442913	499	505	cancer	Disease	MESH:D009369
31442913	590	597	hypoxia	Disease	MESH:D000860
31442913	599	603	iron	Chemical	MESH:D007501
31442913	660	682	Malignant mesothelioma	Disease	MESH:D000086002
31442913	684	686	MM	Disease	MESH:D000086002
31442913	703	708	tumor	Disease	MESH:D009369
31442913	761	769	asbestos	Chemical	MESH:D001194
31442913	810	814	iron	Chemical	MESH:D007501
31442913	834	848	carcinogenesis	Disease	MESH:D063646
31442913	865	868	rat	Species	10116
31442913	869	877	asbestos	Chemical	MESH:D001194
31442913	886	888	MM	Disease	MESH:D000086002
31442913	940	943	CA9	Gene	768
31442913	982	987	human	Species	9606
31442913	1037	1040	CA9	Gene	768
31442913	1063	1067	iron	Chemical	MESH:D007501
31442913	1080	1083	CA9	Gene	768
31442913	1123	1125	MM	Disease	MESH:D000086002
31442913	1140	1146	MeT-5A	CellLine	CVCL:3749
31442913	1200	1207	hypoxia	Disease	MESH:D000860
31442913	1240	1246	Fe(II)	Chemical	-
31442913	1248	1251	CA9	Gene	768
31442913	1286	1290	U104	Chemical	MESH:C585353
31442913	1329	1331	MM	Disease	MESH:D000086002
31442913	1372	1376	TFRC	Gene	7037
31442913	1378	1385	IREB1/2	Gene	48;3658
31442913	1390	1394	FPN1	Gene	30061
31442913	1395	1402	SLC40A1	Gene	30061
31442913	1429	1432	FTH	Gene	2495
31442913	1433	1436	FTL	Gene	2512
31442913	1503	1514	ferroptosis	Disease	
31442913	1629	1635	Fe(II)	Chemical	-
31442913	1677	1680	CA9	Gene	768
31442913	1718	1727	peroxides	Chemical	MESH:D010545
31442913	1743	1746	O2-	Chemical	-
31442913	1751	1756	lipid	Chemical	MESH:D008055
31442913	1826	1838	deferoxamine	Chemical	MESH:D003676
31442913	1840	1853	ferrostatin-1	Chemical	MESH:C573944
31442913	1858	1867	Z-VAD-FMK	Chemical	MESH:C096713
31442913	1902	1913	ferroptosis	Disease	
31442913	1940	1943	CA9	Gene	768
31442913	1980	1987	hypoxia	Disease	MESH:D000860
31442913	1989	1993	iron	Chemical	MESH:D007501
31442913	2029	2031	MM	Disease	MESH:D000086002
31442913	Association	MESH:D001194	MESH:D007501
31442913	Positive_Correlation	2495	768
31442913	Negative_Correlation	MESH:C585353	MESH:D000086002
31442913	Negative_Correlation	7037	768
31442913	Association	MESH:D001194	MESH:D063646
31442913	Association	MESH:D008055	768
31442913	Positive_Correlation	MESH:D001194	MESH:D000086002
31442913	Positive_Correlation	MESH:C585353	48
31442913	Negative_Correlation	48	768
31442913	Association	MESH:D000086002	3658
31442913	Negative_Correlation	MESH:C585353	768
31442913	Negative_Correlation	MESH:C585353	2495
31442913	Association	MESH:D007501	MESH:D063646
31442913	Association	MESH:D000086002	768
31442913	Negative_Correlation	MESH:C585353	2512
31442913	Positive_Correlation	2512	768
31442913	Association	MESH:D000086002	7037
31442913	Negative_Correlation	30061	768
31442913	Association	MESH:D000086002	2495
31442913	Positive_Correlation	MESH:D000860	768
31442913	Positive_Correlation	MESH:C585353	7037
31442913	Negative_Correlation	MESH:D010545	768
31442913	Association	MESH:D000086002	48
31442913	Association	MESH:D007501	MESH:D000086002
31442913	Positive_Correlation	MESH:C585353	30061
31442913	Association	MESH:D000086002	2512
31442913	Positive_Correlation	MESH:C585353	3658
31442913	Negative_Correlation	3658	768
31442913	Association	MESH:D000086002	30061

